ThomasJ.FerroMD

Pulmonology • Richmond, VA

Critical Care Medicine, Pleural Disease

Physician

Join to view full profile

Dr. Ferro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ferro's full profile

Already have an account?

Office
1201 Broad Rock Blvd
Pulmonary Section (111-F)
Richmond, VA 23249
Phone+1 804-675-5605

Fax+1 804-675-5472
Is this information wrong?

Education & Training

University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1983 - 1985
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1980 - 1983
Stony Brook University Health Sciences Center School of MedicineClass of 1980

Certifications & Licensure

NC State Medical License 2008 - 2025
VA State Medical License 1998 - 2008
PA State Medical License 1983 - 1986
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

3 citations
Comparing Ran-Out Status of Inhaled Short-Acting Beta-Agonists in Emergency Department Patients With Acute Asthma: 1996-1998 Versus 2015-2017
Tadahiro Goto, Carlos A. Camargo, Catalina Gimenez-Zapiola, Daniel J. Pallin, Nathan I. Shapiro, Thomas J. Ferro, Carolyn Rainville, Stanislav Stoyanov, Kohei Hasegawa> ;The Journal of Allergy and Clinical Immunology. in Practice. 2018 Nov 1
20 citations
Carbohydrate Differences in HLA-DR Molecules Synthesized by Alveolar Macrophages and Blood Monocytes1–3
Thomas J. Ferro, Dimitri S. Monos, Brett T. Spear, Milton D. Rossman, Chester M. Zmijewski, Malek Kamoun, Ronald P. Daniele> ;The American Review of Respiratory Disease. 2015 May 14
15 citations
Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation
Jill A. Ohar, Glenn Crater, Amanda Emmett, Thomas J. Ferro, Andrea Morris, Ibrahim Raphiou, P. S. Sriram, Mark T. Dransfield> ;Respiratory Research. 2014 Sep 24
16 citations
Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD
François Maltais, Donald A. Mahler, Véronique Pepin, Éric Nadreau, Glenn Crater, Andrea Morris, Amanda Emmett, Thomas J. Ferro> ;The European Respiratory Journal. 2013 Aug 1
76 citations
Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.
Carlos A. Camargo, Louis-Philippe Boulet, E. Rand Sutherland, William W. Busse, Steven W. Yancey, Amanda Emmett, Hector Ortega, Thomas J. Ferro> ;The Journal of Asthma. 2010 Jan 25
21 citations
Poly(ADP-ribose) polymerase-1 regulates vimentin expression in lung cancer cells
Shijian Chu, Haishan Xu, T. J. Ferro, Paola X. Rivera> ;American Journal of Physiology. Lung Cellular and Molecular Physiology. 2007 Nov 1
32 citations
Identification of a hydrogen peroxide-induced PP1-JNK1-Sp1 signaling pathway for gene regulation
Shijian Chu, T. J. Ferro> ;American Journal of Physiology. Lung Cellular and Molecular Physiology. 2006 Jun 30
195 citations
Sp1: regulation of gene expression by phosphorylation.
Shijian Chu, T. J. Ferro> ;Gene. 2005 Mar 28
13 citations
Interferon-γ regulates ClC-2 chloride channel in lung epithelial cells
Shijian Chu, Carol J. Blaisdell, Penelope Bamford, Thomas J. Ferro> ;Biochemical and Biophysical Research Communications. 2004 Nov 5
3 citations
Improving adherence with antimicrobial therapy for respiratory tract infections: a discussion of directly observed therapy (DOT) and short-course therapies.
Douglas B. Schwartz, Alan Adler, Anthony P Dasaro, Ronald J. DeBellis, Robbin Dick, Thomas J. Ferro, Susan Krekun, Rachel L Malina, Peggy S McKinnon, Gregory A. Volturo> ;American Journal of Therapeutics. 2004 Jul 1
Overview of national treatment guidelines for common respiratory tract infections.
Thomas J Ferro> ;American Journal of Therapeutics. 2004 Jul 1
17 citations
Disappearance of microalbuminuria in a patient with type 2 diabetes and the metabolic syndrome in the setting of an intense exercise and dietary program with sustained...
Sonja K. Fredrickson, Thomas J. Ferro, Andrew C. Schutrumpf> ;Diabetes Care. 2004 Jul 1
23 citations
Expression of α-ENaC2 is dependent on an upstream Sp1 binding motif and is modulated by protein phosphatase 1 in lung epithelial cells
Shijian Chu, Charlotte A. Cockrell, Thomas J. Ferro> ;Biochemical and Biophysical Research Communications. 2003 Apr 18
88 citations
Protein kinase C-α mediates endothelial barrier dysfunction induced by TNF-α
T. J. Ferro, Paul Neumann, Nancy Gertzberg, Richard T. Clements, Arnold Johnson> ;American Journal of Physiology. Lung Cellular and Molecular Physiology. 2000 Jun 1
24 citations
Tumor Necrosis Factor- α –Induced Activating Protein-1 Activity Is Modulated by Nitric Oxide–Mediated Protein Kinase G Activation
Nancy Gertzberg, Richard T. Clements, Ilona Jaspers, Thomas J. Ferro, Paul Neumann, Eliezer Flescher, Arnold Johnson> ;American Journal of Respiratory Cell and Molecular Biology. 2000 Jan 1
43 citations
Endothelial barrier dysfunction and p42 oxidation induced by TNF-alpha are mediated by nitric oxide.
Thomas J. Ferro, Nancy Gertzberg, L. Selden, Paul Neumann, Arnold Johnson> ;The American Journal of Physiology. 1997 May 1
99 citations
TNF-alpha induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C
D. T. Phelps, T. J. Ferro, Paul J. Higgins, R. Shankar, D. M. Parker, Arnold Johnson> ;The American Journal of Physiology. 1995 Oct 1
Activation of protein kinase C mediates altered pulmonary vasoreactivity induced by tumor necrosis factor-alpha.
Serfilippi G, Ferro TJ, Johnson A> ;Am. J. Physiol.. 1994-09-01
12 citations
Tumor necrosis factor-alpha decreases pulmonary artery endothelial nitrovasodilator via protein kinase C.
Arnold Johnson, D. T. Phelps, T. J. Ferro> ;The American Journal of Physiology. 1994 Sep 1
Mechanisms of pulmonary edema induced by a diacylglycerol second messenger.
Johnson A, Hocking DC, Ferro TJ> ;Am. J. Physiol.. 1990-01-01
Protein kinase inhibitor prevents pulmonary edema in response to H2O2.
Johnson A, Phillips P, Hocking D, Tsan MF, Ferro T> ;Am. J. Physiol.. 1989-04-01
25 citations
Differential Prostaglandin Production by Unfractionated and Density-Fractionated Human Monocytes and Alveolar Macrophages
Jack A. Elias, Thomas J. Ferro, Milton D. Rossman, Jo Ann Greenberg, Ronald P. Daniele, Alan D. Schreiber, Bruce Freundlich> ;Journal of Leukocyte Biology. 1987 Aug 1
48 citations
Alveolar macrophages, blood monocytes, and density-fractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen.
Thomas J. Ferro, Jeffrey A. Kern, Jack A. Elias, Malek Kamoun, Ronald P. Daniele, Milton D. Rossman> ;The American Review of Respiratory Disease. 1987 Mar 1
19 citations
Diagnosis of pulmonary amyloidosis by transbronchial biopsy.
Lewis R. Kline, Craig A. Dise, Thomas J. Ferro, John Hansen-Flaschen> ;The American Review of Respiratory Disease. 1985 Jul 1
Dextran sulfate inhibits PMN-dependent hydrostatic pulmonary edema induced by tumor necrosis factor.
Hocking, D. C., Ferro, T. J., Johnson, A.> ;J Appl Physiol. 1991 Mar
Join now to see all